Medicinal composition to enhance the synthesis of protoporphyrin IX

摘要

A substance that enhances the conversion of coproporphyrinogen III into protoporphyrin IX for use in the treatment of bacterial infections in a subject through ALD-TFD, where said substance is selected from the group consisting of ethylenediaminetetraacetic acid (EDTA), N acid - (2-hydroxyethyl) iminodiacetic (HI), diethylene triamine pentaacetic acid (DTPA), triethylene tetramine-N, N, N ', N ", N"', N "'- hexaacetic (TT), deferoxamine, malic acid and citric acid .